Robert Philibert on a digital PCR test for addiction


Addiction can be a difficult thing to quantitate. Here Robert Philibert, CEO of Behavioral Diagnostics, discusses the new digital PCR test that can monitor DNA methylation patterns to provide an accurate indication of a patient’s alcohol and cigarette use, allowing physicians to take the self-reporting process out of the addiction diagnosis and treatment protocols.


Check out the rest of our coverage from ASHG 2019 here.